Table 4:

Predictors of Survival among HIV-NSCLC Patients

	Mean Survival Time in years (95% CI)	Log-rank P-value
Age
<62 years	0.99 (0.55, 1.54)	0.12
>62 years	NA (1.48, NA)
Male	0.99 (0.55, 1.54)	0.69
Female	1.46 (0.27, 3.98)
Black, non-Hispanic	1.10 (0.54, 2.42)	0.42
White, non-Hispanic	1.01 (0.07, 1.54)
Hispanic	2.18 (0.96, 15.25)
History of ADI	1.00 (0.48, 1.69)	0.53
No history of ADI	1.48 (0.30, NA)
HIV Viral Load
<400 copies/ml	1.48 (0.87, 2.42)	0.023
>400 copies/ml	0.43 (0.08, 1.68)
On ART	1.22 (0.59, 2.22)	0.26
Off ART	0.66 (0.22, 2.13)
HCV co-infection	0.97 (0.55, 1.68)	0.75
None	1.22 (0.48, 2.42)
Stage I	15.25 (0.87, 15.25)	<0.001
Stage II	2.22 (1.48, NA)
Stage III	0.96 (0.08, 1.68)
Stage IV	0.54 (0.22, 0.99)
	Hazard Ratio per 100 unit increase	P value
CD4 cell count	0.97 (0.83, 1.14)	0.752